{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel",
        "CDC Human Influenza Real-Time RT-PCR Diagnostic Panel"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K132508",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130551"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQW",
        "NSU",
        "NXD",
        "OEP",
        "OZE"
    ],
    "Summary Letter Date": "January 14, 2014",
    "Summary Letter Received Date": "August 12, 2013",
    "Submission Date": "August 9, 2013",
    "Regulation Number(s)": [
        "21CFR866.3980",
        "21CFR866.3332",
        "21CFR862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Reagents for detection of specific novel influenza A viruses",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza virus type A",
        "Influenza virus type B",
        "Influenza A subtypes (seasonal A/H1, A/H3, A/H1pdm09, A/H5)",
        "Genetic lineages of influenza B (B/Victoria, B/Yamagata)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swabs",
        "Nasal swabs",
        "Throat swabs",
        "Nasal aspirates",
        "Nasal washes",
        "Dual nasopharyngeal/throat swabs",
        "Bronchoalveolar lavage",
        "Bronchial wash",
        "Tracheal aspirate",
        "Sputum",
        "Lung tissue",
        "Viral culture"
    ],
    "Specimen Container(s)": [
        "Virus transport medium containing human A549 cells"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems (ABI) 7500 Fast Dx Real-Time PCR Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR (rRT-PCR)",
        "Oligonucleotide primers and dual-labeled hydrolysis (TaqMan) probes"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular lineage genotyping",
        "Nucleic acid sequence analysis"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Test",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel with added influenza B lineage genotyping capability for molecular detection and differentiation of human influenza viruses",
    "Indications for Use Summary": "Qualitative detection and differentiation of influenza virus type A or B, subtyping of influenza A, and genetic lineage determination of influenza B from viral RNA in upper and lower respiratory tract specimens, and viral culture, to support diagnosis, epidemiological surveillance, and presumptive identification of influenza A/H5 (Asian lineage) in conjunction with clinical and epidemiological information",
    "fda_folder": "Microbiology"
}